These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30185546)

  • 1. HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress.
    Nichols BA; Oswald NW; McMillan EA; McGlynn K; Yan J; Kim MS; Saha J; Mallipeddi PL; LaDuke SA; Villalobos PA; Rodriguez-Canales J; Wistuba II; Posner BA; Davis AJ; Minna JD; MacMillan JB; Whitehurst AW
    Cancer Res; 2018 Nov; 78(21):6196-6208. PubMed ID: 30185546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells.
    Gao Y; Kardos J; Yang Y; Tamir TY; Mutter-Rottmayer E; Weissman B; Major MB; Kim WY; Vaziri C
    Sci Rep; 2018 Oct; 8(1):15304. PubMed ID: 30333500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance.
    Zong B; Sun L; Peng Y; Wang Y; Yu Y; Lei J; Zhang Y; Guo S; Li K; Liu S
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.
    Watkins J; Weekes D; Shah V; Gazinska P; Joshi S; Sidhu B; Gillett C; Pinder S; Vanoli F; Jasin M; Mayrhofer M; Isaksson A; Cheang MC; Mirza H; Frankum J; Lord CJ; Ashworth A; Vinayak S; Ford JM; Telli ML; Grigoriadis A; Tutt AN
    Cancer Discov; 2015 May; 5(5):488-505. PubMed ID: 25770156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopically Expressed Meiosis-Specific Cancer Testis Antigen HORMAD1 Promotes Genomic Instability in Squamous Cell Carcinomas.
    Gantchev J; Messina-Pacheco J; Martínez Villarreal A; Ramchatesingh B; Lefrançois P; Xie P; Amar L; Xu HH; Raveendra K; Sikorski D; Guerra Ordaz DJ; Gill RPK; Lambert M; Litvinov IV
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer testes antigen, HORMAD1, limits genomic instability in cancer cells by protecting stalled replication forks.
    Herrera LR; Johnson RA; McGlynn K; Gibbs ZA; Davis AJ; Whitehurst AW
    J Biol Chem; 2023 Nov; 299(11):105348. PubMed ID: 37838177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer.
    Yang Q; Wu J; Luo Y; Huang N; Zhen N; Zhou Y; Sun F; Li Z; Pan Q; Li Y
    Oncotarget; 2016 Sep; 7(38):62585-62597. PubMed ID: 27566579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cancer Testes Antigen, HORMAD1, is a Tumor-Specific Replication Fork Protection Factor.
    Herrera LR; McGlynn K; Gibbs ZA; Davis AJ; Whitehurst AW
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration.
    Huang Z; Sun Z; Zhang X; Niu K; Wang Y; Zheng J; Li H; Liu Y
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30745454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.
    Li J; Wei L
    Biomed Pharmacother; 2019 Jan; 109():519-529. PubMed ID: 30399588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer.
    Maxfield KE; Taus PJ; Corcoran K; Wooten J; Macion J; Zhou Y; Borromeo M; Kollipara RK; Yan J; Xie Y; Xie XJ; Whitehurst AW
    Nat Commun; 2015 Nov; 6():8840. PubMed ID: 26567849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8-MCM9 complex and compromises DNA mismatch repair in cancer cells.
    Liu K; Wang Y; Zhu Q; Li P; Chen J; Tang Z; Shen Y; Cheng X; Lu LY; Liu Y
    Cell Death Dis; 2020 Jul; 11(7):519. PubMed ID: 32647118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
    Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
    J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.